跳至主要内容
临床试验/NCT01778426
NCT01778426已完成不适用

Post-reimbursement Study to Follow Spinal Neurostimulator Devices for Pain Therapy

MedtronicNeuro1 个研究点 分布在 1 个国家目标入组 414 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
414
试验地点
1
主要终点
Percentage of Subjects With at Least 50% Pain Relief in the Area of Predominant Pain at 2 Years

研究概览

简要总结

Observational study to evaluate the long term efficacy of Spinal Cord Stimulation (SCS) over 2 years following SCS implant.

This study is requested by French Health Authorities for reimbursement renewal, to maintain reimbursement for SCS in approved indication in France.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient indicated for Spinal Cord Stimulation (pain therapy)
  • Patient implanted for less than 3 months or hospitalized for the implant of a Medtronic neurostimulator including:
  • primary implant with Spinal Cord Stimulation indication and positive test of stimulation or
  • device replacement of a Medtronic neurostimulator used for Pain Therapy
  • Evaluation of usual pain in the back, upper and lower limbs using a visual analogic scale must be available for the 3 days preceding implant.
  • Treatments must also be available
  • Patient read and signed the data release form

排除标准

  • Patient declined participation
  • Patient is not available for follow up
  • Stimulation of other body part than spinal

结局指标

主要结局

Percentage of Subjects With at Least 50% Pain Relief in the Area of Predominant Pain at 2 Years

时间窗: 2 years

Percentage of primo-implanted subjects who responded to the treatment, where response was defined as a pain relief of at least 50% in the area with predominant pain intensity from baseline to two years follow-up. Pain intensity was assessed using an 11-point (0-10) Numeric Pain Rating Scale (NPRS) ranging from 0 (no pain) to 10 (maximum pain possible).

次要结局

  • Dose of Analgesics Level 3 (Morphinics)(Baseline, 1 and 2 years)
  • Return to Work(1 and 2 years)
  • Percentage of Subjects With at Least 50% Pain Relief in the Area of Predominant Pain at 1 Year(1 year)
  • Patient Satisfaction(1 and 2 years)
  • Percentage of Subjects With at Least 50% Pain Relief in the Area of Non-predominant Pain(1 year and 2 years)
  • Concomitant Pain Relief Medication(Baseline, 1 and 2 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验